Intermolecular (IMI) Tops Q2 Loss Views by 1c; Issues Mixed Q3 Outlook

Intermolecular (NASDAQ: IMI) reported Q2 EPS of $0.00, $0.01 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $16.5 million versus the consensus estimate of $14.88 million.

Intermolecular sees Q3 2012 EPS of $-0.02-$-0.01, versus the consensus of $0.01. Intermolecular sees Q3 2012 revenue of $15.5-$16.0 million, versus the consensus of $14.85 million.

For earnings history and earnings-related data on Intermolecular (IMI) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Keefe, Bruyette & Woods Starts Columbia Financial Inc (CLBK) at Outperform
• Phillip Securities Reiterates Buy Rating on Sea Ltd. (SE)